The Use of Venetoclax + Azacitidine for Acute Myeloid Leukemia & IDH1/2 Mutations Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(10):1,22, May 20, 2022. Favorites PDF Get Content & Permissions Free
First Comprehensive Map Of Human Blood Stem Cell Development Less Oncology Times. 44(9):1,10, May 5, 2022. Favorites PDF Get Content & Permissions Free
Advancing Therapies for Myelodysplastic Syndromes Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(9):1,6, May 5, 2022. Favorites PDF Get Content & Permissions Free
Asciminib (Scemblix®) Hofherr, Mara Lacy Hofherr, Mara Lacy Less Oncology Times. 44(8):17,32, April 20, 2022. Favorites PDF Get Content & Permissions Free
Study Helps Explain Sex Bias, Mechanisms of Rare Leukemia Holt, Chuck Holt, Chuck Less Oncology Times. 44(7):14, April 5, 2022. Favorites PDF Get Content & Permissions Free
Study Solves Protein Structure, Shows How Mutation Drives Blood Cancers Less Oncology Times. 44(7):1,21, April 5, 2022. Favorites PDF Get Content & Permissions Free
Changes in Patterns of Care for Frontline AML Treatment in Older Adults Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(6):1,23, March 20, 2022. Favorites PDF Get Content & Permissions Free
The Incredible Story of Emily Whitehead & CAR T-Cell Therapy Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 44(6):1,19-21, March 20, 2022. Favorites PDF Get Content & Permissions Free
Review of a New Multigenic Autologous CAR T-Cell Therapy Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 44(5):1,17, March 5, 2022. Favorites PDF Get Content & Permissions Free
Exploring Creative Drug Combinations as a Path to Better Patient Outcomes Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 44(5):1,14, March 5, 2022. Favorites PDF Get Content & Permissions Free
Improving Outcomes in Blast Phase Chronic Myeloid Leukemia Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(4):1,20, February 20, 2022. Favorites PDF Get Content & Permissions Free
Survival Rates of Adult Patients With Relapsed ALL After Hematopoietic Cell Transplantation Less Oncology Times. 44(3):1,22, February 5, 2022. Favorites PDF Get Content & Permissions Free
Producing & Using Anti-CD19 CAR T Cells Against B-Cell Malignancies Less Oncology Times. 44(2):24, January 20, 2022. Favorites PDF Get Content & Permissions Free
Expert Perspective: Evaluating Ibrutinib in High-Risk Hairy Cell Leukemia Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(2):1,13, January 20, 2022. Favorites PDF Get Content & Permissions Free
3 QUESTIONS ON... A New Drug Combo for Kids With APL: With Matthew Kutny, MD, of Children's of Alabama and the University of Alabama at Birmingham DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 44(1):34, January 5, 2022. Favorites PDF Get Content & Permissions Free
DNA Sequencing to Predict Leukemia Relapse After CAR-T Therapy Froelich, Warren Froelich, Warren Less Oncology Times. 44(1):1,18, January 5, 2022. Favorites PDF Get Content & Permissions Free
Improving Care & Life for Cancer Patients With CLL Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 43(23):19-20, December 5, 2021. Favorites PDF Get Content & Permissions Free
Progress in Leukemia in 2021: An Optimistic Perspective Kantarjian, Hagop Kantarjian, Hagop Less Oncology Times. 43(23):1,13-17, December 5, 2021. Favorites PDF Get Content & Permissions Free
Double-Vaccinated Blood Cancer Patients Have Poor Immune Response Against COVID-19 Less Oncology Times. 43(22):1,15, November 20, 2021. Favorites PDF Get Content & Permissions Free
Detection & Treatment of AML Via Deep Learning & Population Genetics Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(21):18, November 5, 2021. Favorites PDF Get Content & Permissions Free
TET2: A Promising Therapeutic Target for Pediatric T-ALL Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(21):1,12, November 5, 2021. Favorites PDF Get Content & Permissions Free
How Artificial Intelligence Can Help Diagnose Leukemia Less Oncology Times. 43(20):1,15, October 20, 2021. Favorites PDF Get Content & Permissions Free
Benefits of Immunotherapy After High-Dose Chemo in AML Less Oncology Times. 43(19):26, October 5, 2021. Favorites PDF Get Content & Permissions Free
Advances in Off-the-Shelf Immunotherapy: Expert Discussion Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(19):12-13, October 5, 2021. Favorites PDF Get Content & Permissions Free CME Test
A New Risk Factor for Acute Lymphoblastic Leukemia Less Oncology Times. 43(19):1,16, October 5, 2021. Favorites PDF Get Content & Permissions Free
Genomic Markers of Aggressive Childhood Leukemias Identified Less Oncology Times. 43(18):27, September 20, 2021. Favorites PDF Get Content & Permissions Free
Combination Therapy Provides Remission for Chronic Lymphocytic Leukemia LaCorte, Sarah LaCorte, Sarah Less Oncology Times. 43(18):21-22, September 20, 2021. Favorites PDF Get Content & Permissions Free
The Correlation Between Transplant & Survival in Philadelphia-Like ALL Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 43(17):15-16, September 5, 2021. Favorites PDF Get Content & Permissions Free
Adolescent & Young Adult Enrollment in NCI-Sponsored Clinical Trials Less Oncology Times. 43(17):1,14, September 5, 2021. Favorites PDF Get Content & Permissions Free
Acute Lymphoblastic Leukemia: Research & Therapy in 2021 Kantarjian, Hagop; Jabbour, Elias Kantarjian, Hagop; Jabbour, Elias Less Oncology Times. 43(17):1,11,12,18, September 5, 2021. Favorites PDF Get Content & Permissions Free
Ficlatuzumab + Chemo in Relapsed/Refractory Acute Myeloid Leukemia Gallagher, Amy Gallagher, Amy Less Oncology Times. 43(16):1,15, August 20, 2021. Favorites PDF Get Content & Permissions Free
Mechanisms That Create Individualized Metabolism in Leukemia Less Oncology Times. 43(15):1,13, August 5, 2021. Favorites PDF Get Content & Permissions Free
Mechanism of Leukemia Pathogenesis & Possible Targeted Therapy Holt, Chuck Holt, Chuck Less Oncology Times. 43(15):1,7, August 5, 2021. Favorites PDF Get Content & Permissions Free
Exploring the Link Between Inflammation & Leukemia Less Oncology Times. 43(14):1,12, July 20, 2021. Favorites PDF Get Content & Permissions Free
Understanding Tolerance for Imatinib Nonadherence Among CML Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 43(13):34, July 5, 2021. Favorites PDF Get Content & Permissions Free
Blood Cancer Patients With COVID-19 Fare Better With Convalescent Plasma Less Oncology Times. 43(13):1,12, July 5, 2021. Favorites PDF Get Content & Permissions Free
Combination Therapy Achieves High Response Rates in ALL Less Oncology Times. 43(12):34, June 20, 2021. Favorites PDF Get Content & Permissions Free
Beating Leukemia With a Healthy Diet Change Less Oncology Times. 43(11):1,17, June 5, 2021. Favorites PDF Get Content & Permissions Free
MRD-Positive AML Patients Should Not Proceed Directly to Transplant Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(8):36, April 20, 2021. Favorites PDF Get Content & Permissions Free
More Strategies Needed to Eradicate Minimal Residual Disease in AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(8):34, April 20, 2021. Favorites PDF Get Content & Permissions Free
Deep Learning & Imaging Flow Cytometry for ALL Monitoring Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(7):1,14,17, April 5, 2021. Favorites PDF Get Content & Permissions Free
Reproducing Acute Lymphoblastic Leukemia Surface & Genetic Markers in Cells Holt, Chuck Holt, Chuck Less Oncology Times. 43(5):1,12, March 5, 2021. Favorites PDF Get Content & Permissions Free
New Maintenance Treatment for Acute Myeloid Leukemia Prolongs Lives Less Oncology Times. 43(4):26, February 20, 2021. Favorites PDF Get Content & Permissions Free
Scientists Create On-Off Switches to Control CAR T-Cell Activity Less Oncology Times. 43(4):1,12, February 20, 2021. Favorites PDF Get Content & Permissions Free
Novel Combination Therapy May Help Overcome mTOR Drug Resistance in AML Less Oncology Times. 43(2):24, January 20, 2021. Favorites PDF Get Content & Permissions Free
Decitabine/Cedazuridine (Inqovi®) Lovell, Alexandra Lovell, Alexandra Less Oncology Times. 43(2):15, January 20, 2021. Favorites PDF Get Content & Permissions Free
Venetoclax Combination Improves Outcomes for Patients With Mutated AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 43(2):1,12, January 20, 2021. Favorites PDF Get Content & Permissions Free
Precision Medicine Advances Positive Outcomes in AML Byrd, John C. Byrd, John C. Less Oncology Times. 43(2):1,11, January 20, 2021. Favorites PDF Get Content & Permissions Free
Chemotherapy Plus Blinatumomab Improves Survival for B-Cell ALL Patients Less Oncology Times. 43(1):1,6, January 5, 2021. Favorites PDF Get Content & Permissions Free
Young Survivors of Acute Myeloid Leukemia Have Long-Term Complications Less Oncology Times. 42(24):83-84, December 20, 2020. Favorites PDF Get Content & Permissions Free
Advances in Pediatric Acute Lymphoblastic Leukemia Treatment Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 42(24):6-7, December 20, 2020. Favorites PDF Get Content & Permissions Free CME Test
Reducing GVHD While Retaining Anti-Cancer Effects Less Oncology Times. 42(23):29, December 5, 2020. Favorites PDF Get Content & Permissions Free
Findings Show Superior Patient Outcomes in Beat AML Clinical Trial Less Oncology Times. 42(23):1,16, December 5, 2020. Favorites PDF Get Content & Permissions Free
What Clinicians Treating MDS Patients Must Understand About the TP53 Gene Conick, Hal Conick, Hal Less Oncology Times. 42(21):1,10, November 5, 2020. Favorites PDF Get Content & Permissions Free
Azacitidine Tablets (Onureg®) Shultes, Kendall C. Shultes, Kendall C. Less Oncology Times. 42(20):11,35, October 20, 2020. Favorites PDF Get Content & Permissions Free
A Promising Way to Stop Leukemia Relapse Found in New Research Less Oncology Times. 42(19):1,14, October 5, 2020. Favorites PDF Get Content & Permissions Free
A New Standard of Care for Acute Myeloid Leukemia Holt, Chuck Holt, Chuck Less Oncology Times. 42(19):1,6,14, October 5, 2020. Favorites PDF Get Content & Permissions Free
3 QUESTIONS ON... The Long-Term Benefits of Risk-Stratified Therapy for Childhood ALL: With Stephanie Dixon, MD, of St. Jude Children's Research Hospital DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 42(18):50, September 20, 2020. Favorites PDF Get Content & Permissions Free
New Clinical Practice Guidelines on AML in Older Adults Less Oncology Times. 42(17):1,14, September 5, 2020. Favorites PDF Get Content & Permissions Free
Dual Inhibitor May Be Safer for Chronic Lymphocytic Leukemia Patients Less Oncology Times. 42(15):30, August 5, 2020. Favorites PDF Get Content & Permissions Free
Pathogens Suppress Immune Response With Molecule Less Oncology Times. 42(15):1,29, August 5, 2020. Favorites PDF Get Content & Permissions Free
Long-Term Results Support Efficacy of Ublituximab + Ibrutinib in High-Risk CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(14):36, July 20, 2020. Favorites PDF Get Content & Permissions Free
Long-Term Results Support Efficacy of Ublituximab + Ibrutinib in High-Risk CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(14):36, July 20, 2020. Favorites PDF Get Content & Permissions Free
Precision Medicine Treatments for Children With Leukemia Less Oncology Times. 42(14):1,9, July 20, 2020. Favorites PDF Get Content & Permissions Free
Precision Medicine Treatments for Children With Leukemia Less Oncology Times. 42(14):1,9, July 20, 2020. Favorites PDF Get Content & Permissions Free
Initial Findings Show Promise of Triplet Therapy in CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(13):35, July 5, 2020. Favorites PDF Get Content & Permissions Free
Initial Findings Show Promise of Triplet Therapy in CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(13):35, July 5, 2020. Favorites PDF Get Content & Permissions Free
Bispecific CD19/CD22 CAR T Cells Show Promise in R/R ALL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(11):1,11, June 5, 2020. Favorites PDF Get Content & Permissions Free
Repurposing Classic Chemotherapy Drug to Overcome Therapy Resistance Less Oncology Times. 42(10):1,15, May 20, 2020. Favorites PDF Get Content & Permissions Free
Advances in Dendritic Cell-Based Therapies for Hematologic Malignancies Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 42(8):1,20-21, April 20, 2020. Favorites PDF Get Content & Permissions Free
Cells Leading to Relapse in Acute Lymphoblastic Leukemia Less Oncology Times. 42(6):1,11, March 20, 2020. Favorites PDF Get Content & Permissions Free
CD19 CAR NK-Cell Therapy in Leukemia & Lymphoma Less Oncology Times. 42(5):35, March 5, 2020. Favorites PDF Get Content & Permissions Free
Ibrutinib Plus Venetoclax Shows Promise as First-Line Treatment for CLL Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(3):36, February 5, 2020. Favorites PDF Get Content & Permissions Free
Disparities in Kidney Function Should Not Exclude Minorities From AML Studies Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 42(3):35, February 5, 2020. Favorites PDF Get Content & Permissions Free
Pediatric AML Management After Chemo: Outpatient vs. Inpatient Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(3):34,36, February 5, 2020. Favorites PDF Get Content & Permissions Free
Ibrutinib & Venetoclax as First-Line CLL/SLL Treatment Holt, Chuck Holt, Chuck Less Oncology Times. 42(3):33, February 5, 2020. Favorites PDF Get Content & Permissions Free
A Possible Vaccine for Acute Myeloid Leukemia? Less Oncology Times. 42(3):1,13, February 5, 2020. Favorites PDF Get Content & Permissions Free
Artificial Intelligence Tracks Down Acute Myeloid Leukemia Less Oncology Times. 42(2):33, January 20, 2020. Favorites PDF Get Content & Permissions Free
Acute Leukemia Patients May Have Increased Risk for Heart Failure Less Oncology Times. 42(2):1,15, January 20, 2020. Favorites PDF Get Content & Permissions Free
Putting the Brakes on Dismal Outcomes for Virus-Driven ATLL Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 42(1):18,19,28, January 5, 2020. Favorites PDF Get Content & Permissions Free
Novel Targeted Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm Pemmaraju, Naveen Pemmaraju, Naveen Less Oncology Times. 42(1):1,11-12, January 5, 2020. Favorites PDF Get Content & Permissions Free
Midostaurin (Rydapt®) Lovell, Alexandra Lovell, Alexandra Less Oncology Times. 41(24):5, December 20, 2019. Favorites PDF Get Content & Permissions Free
Chemotherapy Can Set the Stage for Drug-Resistant Leukemia at Relapse Less Oncology Times. 41(24):1,8, December 20, 2019. Favorites PDF Get Content & Permissions Free
Debate: CML Patients With Molecular Response Should Stop Taking TKIs Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(23):1-3, December 5, 2019. Favorites PDF Get Content & Permissions Free
Immunotherapeutic Approaches in Acute Leukemias Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(23):1,15-16, December 5, 2019. Favorites PDF Get Content & Permissions Free
Antibody Eradicates Leukemia Stem Cells Less Oncology Times. 41(22):1,6, November 20, 2019. Favorites PDF Get Content & Permissions Free
Exploring the CLL/Lymphoma Microenvironment to Improve Therapies Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 41(19):1,9-10, October 5, 2019. Favorites PDF Get Content & Permissions Free
Treatment of Patients With Advanced Chronic Myeloid Leukemia Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(19):1,5-6, October 5, 2019. Favorites PDF Get Content & Permissions Free
BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia Strati, Paolo; O'Brien, Susan M. Strati, Paolo; O'Brien, Susan M. Less Oncology Times. 41(17):1,6,7,8,29, September 5, 2019. Favorites PDF Get Content & Permissions Free
Therapy to Treat Drug-Resistant Acute Lymphoblastic Leukemia Less Oncology Times. 41(16):1,7, August 20, 2019. Favorites PDF Get Content & Permissions Free
Childhood Leukemia Cannot Hide From Immune System Less Oncology Times. 41(14):7, July 20, 2019. Favorites PDF Get Content & Permissions Free
EHR Tool Finds Pediatric Leukemia Patients for Clinical Studies Less Oncology Times. 41(14):1,7, July 20, 2019. Favorites PDF Get Content & Permissions Free
SIRT1 Plays Key Role in Chronic Myeloid Leukemia Less Oncology Times. 41(13):1,8, July 5, 2019. Favorites PDF Get Content & Permissions Free
Enasidenib (Idhifa®) Lohr, Lisa Lohr, Lisa Less Oncology Times. 41(12):8, June 20, 2019. Favorites PDF Get Content & Permissions Free
Patterns of Chronic Lymphocytic Leukemia Growth Identified Less Oncology Times. 41(12):1,7, June 20, 2019. Favorites PDF Get Content & Permissions Free
Advice on Charting an Innovative Path Forward for Cell Therapies Eastman, Peggy Eastman, Peggy Less Oncology Times. 41(12):1,4,6, June 20, 2019. Favorites PDF Get Content & Permissions Free
Prolonged Survival Possible in FLT3 Acute Myeloid Leukemia Samson, Kurt Samson, Kurt Less Oncology Times. 41(10):28, May 20, 2019. Favorites PDF Get Content & Permissions Free
Genetic Alterations in Young Adults With Acute Lymphoblastic Leukemia Holt, Chuck Holt, Chuck Less Oncology Times. 41(10):1,8-9, May 20, 2019. Favorites PDF Get Content & Permissions Free
Immunotherapies for Pediatric B-Cell Acute Lymphoblastic Leukemia Patients Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(9):15-18, May 5, 2019. Favorites PDF Get Content & Permissions Free
Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 41(9):1,7,9, May 5, 2019. Favorites PDF Get Content & Permissions Free
